Agnieszka Potasiewicz Selected Research

Agnieszka Potasiewicz Research Topics

9	Schizophrenia (Dementia Praecox) 01/2021 - 05/2013
8	Cognitive Dysfunction 01/2021 - 05/2013
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 10/2016
1	AIDS-Related Complex (ARC) 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021
1	Treatment-Resistant Depressive Disorder 10/2020
1	Memory Disorders (Memory Loss) 01/2020
1	Central Nervous System Diseases (CNS Diseases) 05/2013

5	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021 - 08/2015
5	Ketamine FDA LinkGeneric 10/2020 - 05/2013
2	1- (5- chloro- 2,4- dimethoxyphenyl)- 3- (5- methylisoxazol- 3- yl)ureaIBA 01/2021 - 01/2020
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020 - 08/2015
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2020 - 10/2016
2	Memantine (Namenda)FDA Link 01/2020 - 10/2016
2	Serotonin (5 Hydroxytryptamine)IBA 08/2015 - 05/2013
1	LigandsIBA 01/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	EsketamineIBA 10/2020
1	Donepezil (Aricept)FDA LinkGeneric 01/2020
1	Galantamine (Galanthamine)FDA LinkGeneric 01/2020
1	Methylazoxymethanol AcetateIBA 01/2020
1	NeurotoxinsIBA 01/2020
1	Scopolamine (Hyoscine)FDA Link 01/2020
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	metanicotineIBA 12/2018
1	Cholinergic ReceptorsIBA 12/2018
1	Varenicline (Chantix)FDA Link 12/2018
1	PNU-282987IBA 12/2018
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2017
1	Antipsychotic Agents (Antipsychotics)IBA 01/2017
1	positive allosteric modulator PAM-2IBA 01/2017
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 01/2017
1	3-(2,4-dimethoxybenzylidene)anabaseineIBA 01/2017
1	SCH 23390IBA 01/2016
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 01/2016
1	serotonin 6 receptorIBA 05/2013

2	Therapeutics 01/2017 - 05/2013